Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit yesterday rejected the University of Florida’s argument that its sovereign immunity protected a patent from section 101 scrutiny. 27 February 2019
Generics
A jury has upheld two of Amgen’s patents for its cholesterol drug Repatha, rejecting a challenge brought by two competitors. 26 February 2019
Americas
US-based Merck & Co has announced plans to acquire immunotherapy company Immune Design for $300 million, in a bid to strengthen its capabilities in vaccine development. 26 February 2019
Americas
Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal. 25 February 2019
Europe
Cambridge University has secured a partial trademark victory against Cambridge NeuroTech, a neuroscience biotech company, before the UK Intellectual Property Office. 25 February 2019
Americas
DLA Piper has hired two patent litigators as partners in the firm’s IP and technology practice. 25 February 2019
Americas
American medical device maker ResMed and New Zealand-based competitor Fisher & Paykel have agreed to settle a global patent dispute over medical devices. 22 February 2019
Americas
Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold. 22 February 2019
Americas
The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies. 21 February 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday disqualified law firm Katten Muchin Rosenman from representing Mylan in three appeals before the court. 21 February 2019